A Jhingran

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size
    Anesa Ahamad
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 62:1117-24. 2005
  2. ncbi Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix
    A Jhingran
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 46:1177-83. 2000
  3. ncbi Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas M. D. Anderson Cancer Center experience
    Anuja Jhingran
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 54:804-9. 2002
  4. ncbi Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy
    Anuja Jhingran
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:1366-72. 2003
  5. ncbi Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy
    B M Slomovitz
    Department of Oncology, Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Cancer 15:510-6. 2005
  6. ncbi Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix
    P J Eifel
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Gynecol Cancer 16:1106-11. 2006
  7. ncbi Radiation injury: imaging findings in the chest, abdomen and pelvis after therapeutic radiation
    R Iyer
    Departments of Diagnostic Radiology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Cancer Imaging 6:S131-9. 2006
  8. ncbi New radiation techniques in gynecological cancer
    A Ahamad
    Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA
    Int J Gynecol Cancer 14:569-79. 2004
  9. ncbi Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome
    Ann H Klopp
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:226-36. 2008
  10. ncbi Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy
    Eric A Strom
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:1508-13. 2005

Collaborators

Detail Information

Publications38

  1. ncbi Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size
    Anesa Ahamad
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 62:1117-24. 2005
    ....
  2. ncbi Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix
    A Jhingran
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 46:1177-83. 2000
    ..To evaluate perioperative and postoperative complications of low-dose-rate (LDR) intracavitary radiation therapy in patients with FIGO Stage I-III carcinoma of the uterine cervix...
  3. ncbi Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas M. D. Anderson Cancer Center experience
    Anuja Jhingran
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 54:804-9. 2002
    ..To analyze the long-term outcome of breast conservation therapy in patients with ductal carcinoma in situ (DCIS) in a single institution and to analyze the prognostic importance, if any, of young patient age...
  4. ncbi Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy
    Anuja Jhingran
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:1366-72. 2003
    ..To determine the outcome of patients after radical radiotherapy (RT) for isolated vaginal recurrence of endometrial carcinoma and to determine the clinical and pathologic predictors of outcome...
  5. ncbi Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy
    B M Slomovitz
    Department of Oncology, Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Cancer 15:510-6. 2005
    ..Future prospective clinical trials should consider subclassifying patients with stage IIIA disease to better evaluate the role of adjuvant therapy...
  6. ncbi Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix
    P J Eifel
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Gynecol Cancer 16:1106-11. 2006
    ..The relatively stable annual actuarial risk between 3 and 25 years and the better survival rate after late CDR suggest that most "recurrences" after 3 years are actually new neoplasms...
  7. ncbi Radiation injury: imaging findings in the chest, abdomen and pelvis after therapeutic radiation
    R Iyer
    Departments of Diagnostic Radiology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Cancer Imaging 6:S131-9. 2006
    ..The following will discuss imaging findings that may be seen during imaging surveillance in patients with malignancy affecting the chest, abdomen and pelvis...
  8. ncbi New radiation techniques in gynecological cancer
    A Ahamad
    Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA
    Int J Gynecol Cancer 14:569-79. 2004
    ..Here, we elucidate and illustrate contemporary techniques in radiation oncology, with particular attention paid to the external beam radiotherapy used for adjuvant and primary definitive management of malignancies of the female pelvis...
  9. ncbi Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome
    Ann H Klopp
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:226-36. 2008
    ..In addition we aimed to identify a gene expression profile that was associated with clinical outcome...
  10. ncbi Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy
    Eric A Strom
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:1508-13. 2005
    ....
  11. ncbi Quality of life and sexual functioning in cervical cancer survivors
    Michael Frumovitz
    Department of Gynecologic Oncology, 1155 Herman Pressler, CPB6 3244, Unit 1362, Houston, TX 77030, USA
    J Clin Oncol 23:7428-36. 2005
    ..To compare quality of life and sexual functioning in cervical cancer survivors treated with either radical hysterectomy and lymph node dissection or radiotherapy...
  12. ncbi Uterine cancers
    Benjamin E Greer
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA, USA
    J Natl Compr Canc Netw 4:438-62. 2006
  13. ncbi Advanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy
    Lois M Ramondetta
    Department of Obstetrics and Gynecology, The University of Texas Lyndon Baines Johnson General Hospital, Houston, TX 77230, USA
    Gynecol Oncol 103:547-53. 2006
    ..To document obstacles to completing outpatient treatment faced by indigent patients with cervical cancer and compare treatment costs...
  14. ncbi Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment
    Mylin A Torres
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 70:118-25. 2008
    ..To compare the treatment and outcomes of cervical cancer patients treated with concurrent chemoradiotherapy (CT-RT) in a multi-institutional trial or as standard care...
  15. ncbi Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer
    Michael Frumovitz
    Department of Gynecologic Oncology, CPB6 3244, Unit 1362, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler, Houston, TX 77030, USA
    Gynecol Oncol 108:478-81. 2008
    ..To determine the patterns of lymphatic drainage from primary vaginal cancers utilizing lymphoscintigraphy and to determine if this clinical information would affect treatment planning...
  16. ncbi Retroperitoneal lymph node resection in patients with cervical cancer
    Israel Zighelboim
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology Washington University School of Medicine and Alvin J. Siteman Cancer Center, St. Louis, MO, USA
    Surg Oncol 15:79-83. 2006
    ..002). CONCLUSIONS: The ability to completely resect suspected metastatic lymph nodes at the time of extraperitoneal lymph node dissection in patients with cervical cancer is associated with size and location of largest lymph node...
  17. ncbi Eleven years: the long and winding road
    Lois M Ramondetta
    Gynecol Oncol 107:166-8. 2007
  18. ncbi Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure
    Steven J Frank
    Division of Radiation Oncology, Unit 97, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Gynecol Oncol 105:470-4. 2007
    ..The purpose of this study was to define the pathologic characteristics of verified NDAV and characterize the outcomes of patients who present with this rare malignancy...
  19. ncbi Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116
    William Small
    Department of Radiation Oncology, Robert H Lurie Comprehensive Cancer Center of Northwestern University, 251 E Huron Street, Chicago, IL 60611, USA
    Int J Radiat Oncol Biol Phys 68:1081-7. 2007
    ..This manuscript reports the results of Part 1...
  20. ncbi A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer
    Kent A Gifford
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:615-21. 2005
    ..To determine the effects of Fletcher Suit Delclos ovoid shielding on dose to the bladder and rectum during intracavitary radiotherapy for cervical cancer...
  21. ncbi Radical hysterectomy in obese and morbidly obese women with cervical cancer
    Michael Frumovitz
    Departments of Gynecologic Oncology and Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Obstet Gynecol 112:899-905. 2008
    ....
  22. ncbi A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets
    Lois M Ramondetta
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Gynecol Oncol 90:529-36. 2003
    ..The aim of this study was to determine the efficacy of cisplatin, ifosfamide, and mesna in uterine malignant mixed müllerian tumor (MMMT) and to evaluate the expression of clinically relevant molecular markers...
  23. ncbi Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy
    Mary E Gordinier
    Program in Women's Oncology, Brown University/Women and Infants' Hospital, Providence, RI, USA
    Gynecol Oncol 90:625-8. 2003
    ..SIL as performed on the patients in this study did not eliminate all sites of nodal metastasis...
  24. ncbi Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma
    Wareef Kabbani
    Department of Pathalogy, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 22:297-302. 2003
    ....
  25. ncbi Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome
    Michael Callister
    Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 58:786-96. 2004
    ..Future research should consider programs that integrate surgery, RT, and chemotherapy to maximize the probability of cure...
  26. ncbi Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy
    Thomas A Buchholz
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer J 9:33-41. 2003
    ..We investigated whether changes in tumor cell apoptosis and Bcl-2 expression immediately after chemotherapy correlated with response to breast cancer treatment...
  27. ncbi Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast
    Lawrence J Solin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer 103:1137-46. 2005
    ..The objective of the current study was to determine the long-term outcome after breast-conservation surgery followed by definitive breast irradiation for women with mammographically detected DCIS of the breast...
  28. ncbi Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma
    WARREN D D'SOUZA
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 61:1062-70. 2005
    ..4 Gy and 54 Gy...
  29. ncbi Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer
    Patricia J Eifel
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 20:3651-7. 2002
    ..The purpose of this study was to identify patient-related factors that influence the risk of serious late complications of pelvic radiation therapy...
  30. ncbi Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer
    Christopher E Pelloski
    Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 62:131-7. 2005
    ..In contrast, the dose to the ICRU bladder point does not appear to be a reasonable surrogate for the DBV2. Correlation with late complications are needed to define the role of three-dimensional dosimetry in treatment planning...
  31. ncbi Definitive radiation therapy for squamous cell carcinoma of the vagina
    Steven J Frank
    Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 62:138-47. 2005
    ..Brachytherapy plays an important role in the treatment of many vaginal cancers but should be carefully selected and applied to obtain optimal coverage of the target volume...
  32. ncbi The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva
    Angela Katz
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:409-18. 2003
    ..CONCLUSION: RT alone or in combination with LND is highly effective in preventing INR in patients with squamous cell carcinoma of the vulva and is associated with a low risk of major late complications...
  33. ncbi Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer
    William Small
    Department of Radiation Oncology, Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA
    Int J Radiat Oncol Biol Phys 71:428-34. 2008
    ..To develop an atlas of the clinical target volume (CTV) definitions for postoperative radiotherapy of endometrial and cervical cancer to be used for planning pelvic intensity-modulated radiotherapy...
  34. ncbi Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases
    Brian M Slomovitz
    Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 91:463-9. 2003
    ..Among patients with noninvasive uterine disease, there was a high proportion with abdominal metastasis. Therefore, complete surgical staging of these patients is vital in determining their prognosis...
  35. ncbi Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies
    Anuja Jhingran
    Division of Radiation Oncology, Unit 1202. The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Semin Radiat Oncol 16:144-51. 2006
    ..Therefore, before complete acceptance of IMRT in the treatment of gynecologic malignancies, large multicenter trials are needed to help develop guidelines and standards...
  36. ncbi Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA
    Gynecol Oncol 93:27-33. 2004
    ..Brain metastases were seen only in patients who also had lung metastases, suggesting that prophylactic cranial irradiation would be of little benefit...
  37. ncbi Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: a Monte Carlo study
    Michael J Price
    Department of Radiation Physics, Unit 1220, The University of Texas M.D. Anderson Cancer Center, 1220 Holcombe Blvd, Houston, TX 77030, USA
    Phys Med Biol 50:5075-87. 2005
    ..A validated MC model is the first requirement to simulate common LDR clinical loadings (5-20 mgRaEq) and, thus, will aid in the transition from the current 137Cs Selectron LDR ICBT to PDR for treatment of gynecologic cancers...
  38. ncbi Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ
    Lawrence J Solin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Eur J Cancer 41:1715-23. 2005
    ..Close follow-up after initial breast conservation treatment with radiation is warranted for the early detection of potentially salvageable local and local-regional recurrences...